Oxford Lane Capital is a closed-end investment company that invests primarily in equity and junior debt tranches of collateralized loan obligations (CLOs). It gives public-market investors exposure to the residual and subordinated layers of broadly syndicated leveraged-loan securitizations. The portfolio and distributions are driven by CLO cash flows, credit conditions, and leverage rather than by operating a commercial bank.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2023 | -158.4 | — | -171.3 | — |
| 2024 | 246.7 | — | 235.1 | — |
| 2025 | 57.3 | -76.8% | 48.5 | -79.4% |
| 2026 | -580.2 | -1,112.4% | -585.1 | -1,307.4% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Design Therapeutics, Inc. (DSGN), Daktronics, Inc. (DAKT), Evolv Technologies Holdings, Inc. (EVLV), Annexon, Inc. (ANNX), Bioventus Inc. (BVS), First Financial Corporation (THFF)